Earnings call Caplin Point delivered FY25 revenue of ₹2,034 crore, up 15% YoY, with PAT of ₹541 crore (+17% YoY), and record gross margin of 60.2%. While US growth moderated to 13%, strong execution ...
Shares of Caplin Point Laboratories are in news today after the United States Food and Drug Administration (US FDA) conducted an unannounced inspection of Caplin Steriles’ injectable and ophthalmic ...
Shares of Caplin Point Labs jumped over 13 percent to a fresh 52-week high in trade on August 19, after the Brazilian Health Regulatory Agency concluded its inspection. The regulatory agency or ANVISA ...
CAPLIN POINT LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/02/2025 inter alia to consider and approve The un-audited financial results ...
Caplin Point Laboratories Ltd (CAPL) has delivered a -0.56% share price change over the past year, with a 52-week range between 1,500.30 and 2,395.00 INR. What Is the Average Daily Trading Volume of ...
Over the past 12 months, Caplin Point Laboratories shares have jumped over 90 percent, outperforming the frontline Nifty 50 index. Caplin Point Laboratories shares jumped almost 10 percent in trade on ...
Earnings call Caplin Point Laboratories delivered strong Q2 and H1 FY26 results, with operating revenue up 11% YoY and PAT up 21.6% YoY, significantly exceeding its 25% PAT margin target. Management ...
Promoted by Mr. C. C. Paarthipan, Caplin Point Laboratories Limited was incorporated on April 16, 1990. The Company is presently into the business of pharmaceuticals like producing, developing and ...
Get details on the Caplin Point Laboratories Ltd dividend history and find the CAPL next ex-dividend date. The Caplin Point Laboratories Ltd next dividend payment date and current dividend yield can ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results